Francisco Câmara Ferreira

Francisco Câmara Ferreira


The goal for the Tissue Engineering Platform is to provide the CRG, PRBB and external researchers with the latests technologies used in the fields of stem cell biology, stem cell differentiation, organoid formation  and induced pluripotent stem cells (iPSCs) .  The Unit is constantly setting up new technologies that are emerging in the above fields.

The Tissue Engineering platform works in collaboration with the Biomolecular Screening & Protein Technologies Unit at the CRG to provide CRISPR/Cas9 genome editing technology service.

Laura Batlle CV

Since September 2015: Head of the Tissue Engineering  Facility, CRG, Barcelona, Spain.
2012-2015: Stem cells, Embryology, in vivo procedures and Micromanipulation   Officer, Gene Regulation, Stem Cells and Cancer Programme, CRG, Barcelona, Spain.
2010-2012: Stem Cells and Induced Pluripotent Stem Cells Unit , Mouse Embryo Micromanipulation Manager, CMRB, Barcelona, Spain.
2008-2010: Senior Technician , CMRB, Barcelona, Spain.
2004-2008: PhD in Stem Cell Biology. University Of  Edinburgh, Edinburgh, UK
2004: Research Assistant at Stem Cell Sciences (UK) Ltd.,  Edinburgh, UK.
2003: Research Associate at The Wellcome Trust Center for Cell Biology, University of Edinburgh, Edinburgh, UK.
1999-2003: Bachelors Degree in Biochemistry, Universitat de Barcelona, Barrcelona, Spain.

Funding Acknowledgements

The new Tissue Engineering technological platform offers its services to both CRG and EMBL Barcelona site members. With this purpose, premises have been refurbished and first equipment has been installed, thanks to the co-funding from European Regional Development Funds OP 2014-2020 in Catalonia (reference IU16-005537). Suitable technical staff has also been hired to run the facility.